Results 301 to 303 of about 21,386 (303)

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

Blood, 2008
exaly  

Castleman Disease

Advances in Anatomic Pathology, 2009
exaly  

HIV-Associated Multicentric Castleman’s Disease

2016
Christian Hoffmann, Eric Oksenhendler, Laurence Gérard   +2 more
openaire   +1 more source